4.3 Review

Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Synaptic degeneration in Alzheimer disease

Makis Tzioras et al.

Summary: Alzheimer's disease is a neurodegenerative disorder characterized by cognitive decline and the presence of amyloid-beta and tau protein aggregates in the brain. Synaptic loss plays a crucial role in cognitive decline, and the spread of pathology is mediated by soluble forms of amyloid-beta and tau. Understanding the mechanisms of synaptic degeneration is essential for developing new therapeutic approaches for Alzheimer's disease.

NATURE REVIEWS NEUROLOGY (2023)

Review Cell Biology

c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases

Daniela A. Gutierrez et al.

Summary: This review focuses on the role of the non-receptor tyrosine kinase c-Abl in synaptic and neuronal functions. It has been found that the activation of c-Abl can be detrimental to neurons and may promote the development of neurodegenerative diseases. However, c-Abl activity plays a pivotal role in healthy synaptic plasticity, dendritic spine remodeling, and gene expression regulation after cognitive training.

NEURAL REGENERATION RESEARCH (2023)

Article Medicine, General & Internal

Lecanemab in Early Alzheimer's Disease

Christopher H. van Dyck et al.

Summary: Lecanemab, a humanized monoclonal antibody, reduced amyloid markers and showed improvement in cognition and function in early Alzheimer's disease patients. However, it also resulted in adverse events. Longer trials are needed to determine its efficacy and safety in early Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Cell Biology

The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease

Senthilkumar S. Karuppagounder et al.

Summary: Parkinson's disease (PD) is a prevalent neurodegenerative disease with millions of cases worldwide. The activation of Abelson tyrosine kinase (c-Abl) is involved in the initiation and progression of PD, leading to the degeneration of neurons. A c-Abl inhibitor called IkT-148009 has shown potential in protecting dopaminergic neurons and improving motor function in mouse models of PD.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Review Medicine, Research & Experimental

Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series

Arsh Haj Mohamad Ebrahim Ketabforoush et al.

Summary: Amyotrophic Lateral Sclerosis (ALS) is a debilitating neurodegenerative disease affecting upper and lower motor neurons. Despite the approval of a few drugs, the survival rate and quality of life for ALS patients remain low. Masitinib, a tyrosine kinase inhibitor, has shown promising results in clinical trials by targeting neuro-inflammation and inducing neuroprotection. This review discusses the pathophysiology of ALS, the mechanism of action of Masitinib, and its potential as a treatment for ALS, along with other drugs in phase 3 clinical trials.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Environmental Sciences

Mechanism of autophagy mediated by IGF-1 signaling pathway in the neurotoxicity of lead in pubertal rats

Bo Zhang et al.

Summary: This study aimed to elucidate the molecular mechanisms of cognitive impairment in rats following chronic lead exposure and mitigate or prevent lead toxicity in the central nervous system. Lead exposure caused significant damage to rat nervous systems, including increased autophagosomes in hippocampal neurons, decreased IGF-1 levels, decreased gene expression of IGF-1, IGF-1R, PI3K, Akt, and mTOR, and upregulated levels of autophagy-associated proteins. In vivo intervention experiments using an autophagy inhibitor showed that it inhibited lead-induced autophagy and autophagy-related gene expression, possibly through activation of the IGF-1 pathway. Overall, lead may activate hippocampal autophagy through the IGF-1/PI3K/Akt/mTOR signaling pathway.

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2023)

Article Multidisciplinary Sciences

Single-cell-led drug repurposing for Alzheimer's disease

Silvia Parolo et al.

Summary: This article presents a single-cell-led systems biology pipeline for identifying drug repurposing candidates for Alzheimer's disease. Through computational analysis, 54 potential drugs targeting MAPK and IGF1R signaling pathways were discovered.

SCIENTIFIC REPORTS (2023)

Article Biochemistry & Molecular Biology

Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model

Xiao-ying Sun et al.

Summary: Passive immunotherapy is a promising intervention for Alzheimer's disease (AD), but immune-modulating strategies often fail in clinical trials. By studying A beta-targeting antibodies, researchers found that their interaction with microglial cells can lead to synaptic engulfment and exacerbate cognitive deficits and neuroinflammation. However, antibodies without Fc fragment or with reduced Fc effector function may provide a safer and more efficient alternative for AD immunotherapy.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Review Biochemistry & Molecular Biology

BDNF signaling in context: From synaptic regulation to psychiatric disorders

Camille S. Wang et al.

Summary: This review examines the importance of spatial and temporal factors on BDNF activity, particularly in processes such as synaptogenesis, plasticity, and psychiatric disorder treatment. Understanding the fundamental physiology of BDNF and new approaches to control its signaling in time and space can lead to improved therapeutics and patient outcomes.
Review Neurosciences

Mechanistic and therapeutic implications of EphA-4 receptor tyrosine kinase in the pathogenesis of Alzheimer's disease

Devargya Ganguly et al.

Summary: EphA-4 plays a significant role in the onset and progression of Alzheimer's disease. Inhibition of EphA-4 can alleviate symptoms and affect the development of the disease. Further research on the regulation pathways of EphA-4 and the development of therapeutic methods targeting its enzymatic activity are important.

EUROPEAN JOURNAL OF NEUROSCIENCE (2022)

Article Engineering, Environmental

BDE-47 induced PC-12 cell differentiation via TrkA downstream pathways and caused the loss of hippocampal neurons in BALB/c mice

Dongmeng Liu et al.

Summary: Research has shown that BDE-47 can lead to changes in cell morphology, apoptosis, and ROS production in PC-12 cells, as well as promote cell differentiation. Animal studies confirmed that BDE-47 causes a decrease in neurons in the brain, and transcriptome sequencing revealed significant regulation of multiple signaling pathways related to neuron death and nerve function.

JOURNAL OF HAZARDOUS MATERIALS (2022)

Article Gastroenterology & Hepatology

Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma

Abdullah Husain et al.

Summary: In hepatocellular carcinoma (HCC), the Ephrin-A3/EphA2 axis plays a significant role as a hypoxia-sensitive modulator of HCC cell metabolism and a key contributor to HCC initiation and progression.

JOURNAL OF HEPATOLOGY (2022)

Review Biochemistry & Molecular Biology

Brain-Derived Neurotropic Factor in Neurodegenerative Disorders

Abdallah Mohammad Ibrahim et al.

Summary: Globally, neurodegenerative diseases lead to significant disability and distress. Brain-derived neurotrophic factor (BDNF) plays a crucial role in the development and maintenance of various nerve functions and is associated with the family of neurotrophins. Decreased levels of BDNF have been shown to disrupt neuronal functioning and survival. Additionally, BDNF is involved in synaptic plasticity and long-term memory formation. Studies have linked BDNF to the pathology of common neurodegenerative disorders like Alzheimer's and Parkinson's disease, with higher levels of BDNF associated with lower risk.

BIOMEDICINES (2022)

Review Cell Biology

Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease

Zeyu Yin et al.

Summary: This review summarizes the research on the role of Tec kinases in cardiovascular disease, providing new insights into the prevention and treatment of cardiovascular disease.

CELL DEATH DISCOVERY (2022)

Review Medicine, Research & Experimental

The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer?s disease

Xia Zhao et al.

Summary: Protein tyrosine phosphatases (PTPs) play a significant role in the pathogenesis of Alzheimer's disease (AD) and are closely related to the accumulation of abnormally phosphorylated proteins.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Neurosciences

The Role of Brain-Derived Neurotrophic Factor Signaling in Central Nervous System Disease Pathogenesis

Shu-Hui Dou et al.

Summary: This article reviews the abnormal levels of brain-derived neurotrophic factor (BDNF) in various central nervous system (CNS) diseases and suggests that BDNF may play a role in the pathogenesis of these diseases. It also discusses the potential treatment of these diseases by regulating BDNF signaling. The clinical application status of BDNF is briefly introduced.

FRONTIERS IN HUMAN NEUROSCIENCE (2022)

Review Medicine, Research & Experimental

Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders

Jordi Olloquequi et al.

Summary: PTP1B is a potential target for the treatment of neurological diseases, as its activation in brain cells can lead to various neuronal deficits. However, inhibition of PTP1B has shown promising therapeutic effects and potential to improve cognitive processes. Clinical trials evaluating the neurological benefits of PTP1B inhibition are still needed.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Clinical Neurology

Bruton's Tyrosine Kinase Inhibition in Multiple Sclerosis

Raphael Schneider et al.

Summary: Multiple sclerosis is an inflammatory disease of the central nervous system with limited treatment options. New experimental therapy, such as Bruton's Tyrosine Kinase Inhibitors (BTKIs), shows potential in targeting the immunopathology of the central nervous system. There are ongoing clinical trials to evaluate the efficacy and safety of BTKIs in different forms of multiple sclerosis.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2022)

Editorial Material Biochemistry & Molecular Biology

Neurodegenerative Diseases: From Molecular Basis to Therapy

Luisa Agnello et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Automation & Control Systems

Multimodal Gait Recognition for Neurodegenerative Diseases

Aite Zhao et al.

Summary: This article proposes a novel hybrid model to learn gait differences between different neurodegenerative diseases, Parkinson's disease severity levels, and healthy individuals and patients through fusion and aggregation of data from multiple sensors. The model utilizes a spatial feature extractor and a new correlative memory neural network architecture to capture temporal information, along with a multiswitch discriminator to associate observations with individual state estimations. Compared to several state-of-the-art techniques, the framework shows more accurate classification results.

IEEE TRANSACTIONS ON CYBERNETICS (2022)

Review Pharmacology & Pharmacy

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers

Tingting Jiang et al.

Summary: TRKA, TRKB, and TRKC are important members of the cell surface receptor tyrosine kinase family, regulating cell proliferation, differentiation, and apoptosis. NTRK gene fusions act as oncogenic drivers for a variety of tumors, making TRK inhibitors promising targets for anti-tumor therapy.

ACTA PHARMACEUTICA SINICA B (2021)

Article Neurosciences

TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway

John Bosco Ruganzu et al.

Summary: The overexpression of TREM2 was found to rescue cognitive deficits, reduce Aβ plaque deposition, decrease synaptic and neuronal loss, as well as ameliorate neuroinflammation, likely through the inhibition of neuroinflammatory responses via the JAK/STAT/SOCS signaling pathway and promotion of M2 microglia activation. This study highlights TREM2 as a potential target against AD by shifting microglia from an M1 to M2 phenotype.

EXPERIMENTAL NEUROLOGY (2021)

Article Neurosciences

EphA1 Activation Induces Neuropathological Changes in a Mouse Model of Parkinson's Disease Through the CXCL12/CXCR4 Signaling Pathway

Jianjun Ma et al.

Summary: The involvement of EphA1 in the function and development of the central nervous system, especially in neuroinflammation, has been increasingly evidenced. It has been found to impact disease progression in Alzheimer's and Parkinson's diseases by regulating neuroinflammatory processes. Through in vivo and in vitro studies using mice and PD cell models, EphA1 was shown to improve inflammatory responses and neuropathological changes in PD models through the CXCL12/CXCR4 signaling pathway.

MOLECULAR NEUROBIOLOGY (2021)

Article Chemistry, Multidisciplinary

Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model

Lei Zhu et al.

Summary: This study demonstrates the potential therapeutic effect of PF11 in managing Alzheimer's disease by improving cognitive function, reducing neuronal loss, protecting synapse structure, and modulating tau phosphorylation in the hippocampus. The results indicate that PF11 may be a promising treatment option for Alzheimer's disease.

ACTA PHARMACOLOGICA SINICA (2021)

Article Biochemistry & Molecular Biology

Tyrosine phosphorylation regulates hnRNPA2 granule protein partitioning and reduces neurodegeneration

Veronica H. Ryan et al.

Summary: mRNA transport in neurons requires the formation of transport granules containing various protein components. Mutations in the hnRNPA2 protein can lead to increased aggregation and hereditary proteinopathy of neurons, myocytes, and bone. In vitro studies have shown that alterations in phosphorylation status of hnRNPA2 can affect its phase separation, partitioning specificity, assembly/disassembly, and link to neurodegenerative diseases.

EMBO JOURNAL (2021)

Review Cell Biology

MMP-9 Signaling Pathways That Engage Rho GTPases in Brain Plasticity

Izabela Figiel et al.

Summary: The extracellular matrix plays a critical role in synaptic function, with MMP-9 and Rho GTPases identified as key factors in regulating synaptic plasticity. MMP-9 contributes to dynamic remodeling by cleaving ECM components, while Rho GTPases control cellular processes in brain physiology and pathology.

CELLS (2021)

Article Endocrinology & Metabolism

Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta

Andrea Tumminia et al.

Summary: This study compared the content and phosphorylation of IR and IGF-1R in the placenta of women with T1D or GDM to women with NGT during pregnancy. The study found that T1D patients had higher rates of adverse outcomes, and both T1D and GDM women showed a positive correlation between phosphorylation levels and blood glucose levels. Increased IGF-1R phosphorylation and IR-A expression in the placenta of T1D patients were associated with increased maternal blood glucose levels, which could promote excessive fetal growth.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Chemistry, Multidisciplinary

Supramolecular Self-Assembly-Facilitated Aggregation of Tumor-Specific Transmembrane Receptors for Signaling Activation and Converting Immunologically Cold to Hot Tumors

Jun Li et al.

Summary: Supramolecular self-assembling peptide systems have shown great potential for cancer theranostics, with the ability to target specific receptors and promote antitumor responses. The designed peptide agent can visualize and suppress cancer cell proliferation by targeting EphA2 receptors, and also convert immunologically cold tumors to hot by inducing immunogenic cell death and recruiting tumor-infiltrating T cells. This study introduces a new category of agents capable of converting cold to hot tumors through supramolecular self-assembly.

ADVANCED MATERIALS (2021)

Review Biochemistry & Molecular Biology

Galectins as modulators of receptor tyrosine kinases signaling in health and disease

Natalia Porebska et al.

Summary: This article explores the collaboration between receptor tyrosine kinases (RTKs) and the galectin family of carbohydrate binding proteins, highlighting their significance in cellular physiology in both healthy tissues and cancer.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Article Neurosciences

Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2

Kazunori Sano et al.

Summary: The phosphorylation of alpha synuclein at Y136 in the Lewy body dementia brain is mediated by the unexpected kinase activity of CK2. CK2 can promote aggregate formation of r-alpha Syn with phosphorylation at S129 and Y136, while its inhibition attenuates the formation of aggregates with S129 phosphorylation and unexpectedly increases phosphorylation at Y136.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Cell Biology

Diversity of insulin and IGF signaling in breast cancer: Implications for therapy

Michael W. Lero et al.

Summary: This review underscores the significance of the IR/IGF-1R signaling pathway in cancer and its potential as a therapeutic target. Understanding the pathway's role in normal mammary gland function provides insight into its aberrations in breast cancer. However, efforts to target this pathway for cancer treatment are hindered by a lack of biomarkers and adverse effects on normal metabolism.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)

Review Neurosciences

Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor

Kathryn M. Miller et al.

Summary: This review highlights the impact of alpha-synuclein on cellular dysfunction in Parkinson's disease and its potential disease-modifying effects, with a special emphasis on the importance of BDNF in this process.

NPJ PARKINSONS DISEASE (2021)

Article

Emphasizing roles of BDNF promoters and inducers in Alzheimer's disease for improving impaired cognition and memory

Madhuparna Banerjee et al.

Journal of Basic and Clinical Physiology and Pharmacology (2021)

Article Cell Biology

The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling

Jessica Fiebelkow et al.

Summary: The study shows that SHP2 not only increases robustness of basal and cytokine-induced STAT3 activity, but also ensures information transmission. SHP2 increases the dynamic range of pathway activation in JAK/STAT signalling, contributing to communication in multicellular organisms.

CELL COMMUNICATION AND SIGNALING (2021)

Review Biochemistry & Molecular Biology

Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer

Aldona Kasprzak

Summary: Colorectal cancer is a common aggressive carcinoma with poor prognosis, often associated with metabolic syndrome and high blood sugar levels. The role of IGF-1 in glucose metabolism in colorectal carcinogenesis and its potential link to the Warburg effect require further investigation. Current therapeutic strategies targeting impaired glucose metabolism in CRC are being explored to improve treatment outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview

Mattias F. Lindberg et al.

Summary: DYRK and CLK kinases are involved in various cellular functions and their abnormal expression/activity are linked to multiple neurological diseases, cancers, and other conditions. Research on the regulation of these kinases and the development of inhibitors is crucial for the treatment of related diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

The Implication of STEP in Synaptic Plasticity and Cognitive Impairments in Alzheimer's Disease and Other Neurological Disorders

Yacoubou Abdoul Razak Mahaman et al.

Summary: STEP is a tyrosine phosphatase implicated in Alzheimer's disease and other neurological disorders. Its dysregulation leads to inactivation of proteins related to synaptic plasticity, resulting in synapse loss and cognitive impairments. Targeting STEP may be a potential therapeutic strategy for these diseases.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Medicine, Research & Experimental

IGF-1 Protects Neurons in the Cortex and Subventricular Zone in a Periventricular Leucomalacia Model

Dong-Joon Kim et al.

Summary: The study found that insulin-like growth factor-1 can increase the number of early neuronal cells and decrease the number of mature neurons in a periventricular leucomalacia model in rats, thus effectively reversing this phenomenon.

IN VIVO (2021)

Article Clinical Neurology

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

Jesus S. Mora et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)

Article Immunology

The role of JAK/STAT signaling pathway and its inhibitors in diseases

Ping Xin et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Article Neurosciences

α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment

Md. Razaul Karim et al.

MOLECULAR NEURODEGENERATION (2020)

Article Clinical Neurology

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer's disease

Francois Mouton-Liger et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Review Biochemistry & Molecular Biology

Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer

Luca Colucci-D'Amato et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Editorial Material Chemistry, Medicinal

Advances in Studies on Neurodegenerative Diseases and their Treatments

Satya P. Gupta

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)

Review Neurosciences

PINK1/PARKIN signalling in neurodegeneration and neuroinflammation

Peter M. J. Quinn et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

The Role of Tyrosine Phosphorylation of Protein Kinase C Delta in Infection and Inflammation

Qingliang Yang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer's disease models

Yehong Du et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)

Review Biochemistry & Molecular Biology

PDGF/PDGFR axis in the neural systems

Susmita Sil et al.

MOLECULAR ASPECTS OF MEDICINE (2018)

Review Biotechnology & Applied Microbiology

Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers

Chung-Ting Jimmy Kou et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Review Chemistry, Multidisciplinary

Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases

Zhi-Hong Yu et al.

CHEMICAL REVIEWS (2018)

Review Neurosciences

Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier

Prita R. Asih et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Cell Biology

Pathology of Neurodegenerative Diseases

Brittany N. Dugger et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Article Clinical Neurology

Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration

Sebastian A. Lewandowski et al.

ACTA NEUROPATHOLOGICA (2016)

Review Neurosciences

Proteolytic processing of Neuregulin-1

Michael Willem

BRAIN RESEARCH BULLETIN (2016)

Review Geriatrics & Gerontology

Growth hormone, insulin-like growth factor-1 and the aging brain

Nicole M. Ashpole et al.

EXPERIMENTAL GERONTOLOGY (2015)

Article Neurosciences

Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes

Abhay P. Sagare et al.

NEUROSCIENCE LETTERS (2015)

Review Pharmacology & Pharmacy

Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

Christiane Reitz et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Review Medical Laboratory Technology

Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells

Elzbieta Gocek et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2014)

Article Food Science & Technology

Effects of C-glycosylation on anti-diabetic, anti-Alzheimer's disease and anti-inflammatory potential of apigenin

Jae Sue Choi et al.

FOOD AND CHEMICAL TOXICOLOGY (2014)

Article Biochemistry & Molecular Biology

Withania somnifera Alleviates Parkinsonian Phenotypes by Inhibiting Apoptotic Pathways in Dopaminergic Neurons

Jay Prakash et al.

NEUROCHEMICAL RESEARCH (2014)

Review Cell Biology

Tau protein kinases: Involvement in Alzheimer's disease

Ludovic Martin et al.

AGEING RESEARCH REVIEWS (2013)

Article Neurosciences

Necl-2/CADM1 interacts with ErbB4 and regulates its activity in GABAergic neurons

Akio Yamada et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2013)

Article Biochemistry & Molecular Biology

Neuroprotective Role of Withania somnifera Root Extract in Maneb-Paraquat Induced Mouse Model of Parkinsonism

Jay Prakash et al.

NEUROCHEMICAL RESEARCH (2013)

Review Cell Biology

Eph receptors at synapses: Implications in neurodegenerative diseases

Yu Chen et al.

CELLULAR SIGNALLING (2012)

Article Biochemistry & Molecular Biology

First and Second Generation γ-Secretase Modulators (GSMs) Modulate Amyloid-β (Aβ) Peptide Production through Different Mechanisms

Tomas Borgegard et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Review Neurosciences

Ephrin regulation of synapse formation, function and plasticity

Martin Hruska et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2012)

Article Multidisciplinary Sciences

Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease

Maria Bjorkqvist et al.

PLOS ONE (2012)

Article Biochemistry & Molecular Biology

c-Abl in Neurodegenerative Disease

Sarah D. Schlatterer et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2011)

Article Geriatrics & Gerontology

c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice

Gonzalo I. Cancino et al.

NEUROBIOLOGY OF AGING (2011)

Article Biochemistry & Molecular Biology

ErbB4-Neuregulin Signaling Modulates Synapse Development and Dendritic Arborization through Distinct Mechanisms

Daria Krivosheya et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Tyrosine phosphorylation of ErbB4 is enhanced by PSD95 and repressed by protein tyrosine phosphatase receptor type Z

Akihiro Fujikawa et al.

JOURNAL OF BIOCHEMISTRY (2007)

Review Pharmacology & Pharmacy

Receptor tyrosine kinases and anticancer therapy

M Medinger et al.

CURRENT PHARMACEUTICAL DESIGN (2005)

Article Multidisciplinary Sciences

Crystal structure of an Eph receptor-ephrin complex

JP Himanen et al.

NATURE (2001)